Can Crestor (rosuvastatin) raise liver enzymes?
Yes. Like other statins, Crestor can increase liver enzyme levels on blood tests, especially early in treatment. These lab elevations are typically mild and reversible, but they can also be significant in some people. Patients usually get a baseline liver test before starting, with follow-up testing if symptoms or lab abnormalities show up.
What do “elevated liver enzymes” mean with Crestor?
Clinicians typically watch for rises in enzymes such as ALT and AST. If levels rise substantially or continue to climb, a clinician may lower the dose, pause treatment, or stop Crestor depending on how high the results are and whether symptoms are present.
What symptoms would suggest a liver problem while on Crestor?
If a patient develops symptoms that can occur with liver injury, they should contact a clinician promptly. Common warning signs include unusual fatigue, weakness, loss of appetite, nausea/vomiting, abdominal pain (especially right upper abdomen), dark urine, pale stools, or yellowing of the skin/eyes (jaundice).
How common is liver enzyme elevation with statins?
Mild ALT/AST elevations are relatively common with statins, but serious liver injury is uncommon. The risk tends to be higher with higher doses and in people with certain risk factors (for example, existing liver disease, heavy alcohol use, or interacting medications).
Does alcohol or other meds increase the risk?
Yes. Alcohol and other liver stressors can increase risk. Some medications also raise statin exposure or increase the chance of adverse effects. If you take other drugs regularly (especially ones that interact with statins), it’s important to review them with your prescriber or pharmacist so they can check for interactions.
What should I do if my liver enzymes come back high?
Follow your clinician’s plan for repeat labs and monitoring. Don’t stop Crestor on your own without medical guidance. In many cases clinicians repeat liver tests to confirm the pattern (since transient elevations can happen), then decide whether to continue, adjust the dose, or change therapy based on the degree of elevation and symptoms.
If it’s not safe to continue Crestor, what alternatives exist?
If liver enzymes stay elevated or symptoms suggest liver injury, clinicians may switch to a different lipid-lowering approach or a different statin strategy (sometimes using a lower dose or an alternative agent), depending on your cardiovascular risk and the lab pattern.
Where do patents come in for Crestor?
If your interest is also about Crestor and liver-related safety labeling tied to ongoing generic/brand competition, DrugPatentWatch.com tracks Crestor-related patent and exclusivity information. You can search: https://www.drugpatentwatch.com/ (or look up “Crestor/rosuvastatin” there).
Sources
- DrugPatentWatch.com (Crestor/rosuvastatin patent tracking): https://www.drugpatentwatch.com/